Schedule 13G ownership disclosure
PMV PHARMACEUTICALS INC
Common Stock, $0.00001 par value per share · CUSIP: 69353Y103
Event date: 2025-12-31
- Filing-level shares
- 5,292,000
- Percent of class
- 9.9%
- BML Investment Partners, L.P.
Shares: 5,292,000 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-26-000014
- Form type
- SCHEDULE 13G/A
- Filer
- BML Investment Partners, L.P.
- CIK
- CIK 1373604
- Filed
- Feb 09, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership